Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

about

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

Item

http://www.wikidata.org/entity/Q36636361

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

@ast

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

@en

type

Item

label

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

@ast

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

@en

prefLabel

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

@ast

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

@en

P1476

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease.

@en

P2093

Amin Saburi

http://www.w3.org/2001/XMLSchema#string

Hossein Khedmat

http://www.w3.org/2001/XMLSchema#string

Mohammad Bigdeli

http://www.w3.org/2001/XMLSchema#string

Nematollah Jonaidi-Jafari

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Study of iron metabolism disturbances in an animal model of insulin resistance

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.

The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.

Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study.

Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity.

Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.

Nonalcoholic fatty liver disease: a review and update.

Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.

P304

31-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15171/MEJDD.2016.04

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Ebrahim Ghamar Chehreh

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26933479

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

4773080

http://www.w3.org/2001/XMLSchema#string